Life Healthcare Group Holdings Limited

JSE:LHC Stock Report

Market Cap: R23.2b

Life Healthcare Group Holdings Future Growth

Future criteria checks 1/6

Life Healthcare Group Holdings is forecast to grow earnings and revenue by 7.5% and 5% per annum respectively. EPS is expected to grow by 6.7% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

7.5%

Earnings growth rate

6.7%

EPS growth rate

Healthcare earnings growth26.1%
Revenue growth rate5.0%
Future return on equity17.2%
Analyst coverage

Good

Last updated23 Jan 2025

Recent future growth updates

Recent updates

Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

May 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

Apr 28
Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

Feb 08
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Jan 25
There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Jan 08
With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Nov 28
Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Oct 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

Aug 16
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Jul 20
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Earnings and Revenue Growth Forecasts

JSE:LHC - Analysts future estimates and past financials data (ZAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202730,0532,5287044,0334
9/30/202628,1902,0761,0614,1687
9/30/202526,7691,9677883,9206
9/30/202425,7911,9862,1703,723N/A
6/30/202424,7761,6982,5624,140N/A
3/31/202423,7611,4102,9544,556N/A
12/31/202323,3261,3323,0514,613N/A
9/30/202322,8901,2543,1474,670N/A
3/31/202318,0781,2252,5513,494N/A
12/31/202219,4141,2652,6543,839N/A
9/30/202220,7501,3052,7574,184N/A
3/31/202227,6211,5442,2184,615N/A
12/31/202127,3401,6062,7314,879N/A
9/30/202127,0591,6673,2435,142N/A
3/31/202124,5956292,6784,128N/A
12/31/202024,2996682,3784,085N/A
9/30/202024,0037062,0774,041N/A
6/30/202025,0061,860N/AN/AN/A
3/31/202026,0093,0142,2754,555N/A
12/31/201925,9572,7922,4354,605N/A
9/30/201925,9042,5692,5954,655N/A
6/30/201925,3481,8622,3444,518N/A
3/31/201924,7921,1552,0934,380N/A
12/31/201824,2541,3652,1454,410N/A
9/30/201823,7161,5752,1964,440N/A
6/30/201823,1841,511N/A4,427N/A
3/31/201822,6521,447N/A4,413N/A
12/31/201721,8101,131N/A4,069N/A
9/30/201720,967814N/A3,724N/A
6/30/201719,656805N/A3,494N/A
3/31/201718,345795N/A3,263N/A
12/31/201617,4561,206N/A3,159N/A
9/30/201616,5671,616N/A3,055N/A
6/30/201616,0341,808N/A3,076N/A
3/31/201615,5001,999N/A3,096N/A
12/31/201515,1381,933N/A3,024N/A
9/30/201514,7761,866N/A2,951N/A
6/30/201514,3791,830N/A2,809N/A
3/31/201513,9821,793N/A2,667N/A
12/31/201413,5452,284N/A2,602N/A
9/30/201413,1072,774N/A2,536N/A
6/30/201412,7952,772N/A2,642N/A
3/31/201412,4832,770N/A2,748N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LHC's forecast earnings growth (7.5% per year) is below the savings rate (9.7%).

Earnings vs Market: LHC's earnings (7.5% per year) are forecast to grow slower than the ZA market (20.3% per year).

High Growth Earnings: LHC's earnings are forecast to grow, but not significantly.

Revenue vs Market: LHC's revenue (5% per year) is forecast to grow faster than the ZA market (4.3% per year).

High Growth Revenue: LHC's revenue (5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LHC's Return on Equity is forecast to be low in 3 years time (17.2%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 16:20
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Life Healthcare Group Holdings Limited is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rendani MagalelaAbsa Bank Limited
Sean UngererArqaam Capital Research Offshore S.A.L.
Simon MatherBarclays